Asia-Pacific Medical Affairs Outsourcing Market Growth Opportunities and Forecast by 2027

Historic Data: 2018-2019 | Base Year: 2020 | Forecast Period: 2021-2027

Asia-Pacific Medical Affairs Outsourcing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Services (Medical Writing and Publishing, Medical Monitoring, Medical Science Liaisons (MSLs), Medical Information, and Others) and Application (Pharmaceutical, Biopharmaceutical, and Medical Devices)

Report Date : Oct 2021
Report Code : TIPRE00025181

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 134

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The medical affairs outsourcing market in APAC is expected to grow from US$ 356.69 million in 2020 to US$ 776.42 million by 2027; it is estimated to grow at a CAGR of 11.8% from 2020 to 2027.

Australia, China, India, Japan, and South Korea are major economies in APAC. Rising market collaboration is the major factor driving the growth of the APAC medical affairs outsourcing market. The contract research organization (CRO) services’ industry is highly fragmented, with several hundred small and medium-sized limited-service providers, and a small number of large, full-service, APAC CROs. There are few barriers to entry for smaller CROs into the APAC market, whereas a full-service CRO with APAC capabilities requires building the necessary infrastructure with the ability to simultaneously manage multiple complex testing services across numerous geographies, establishing the requisite relationships with strategic partners, developing relevant therapeutic and development of expertise to serve the needs of the end users. Over the past few years, the consolidation across the industry is an emerging trend followed by the majority of the prime players to strengthen their service offerings and garner the major market share in the APAC CRO market. For instance, For instance, Parexel International Corp. acquired The Medical Affairs Company in 2017. This has led to the generation of larger CROs with the wide geographic diversification, extensive therapeutic and development expertise, enormous capital and technical resources to manage the demanding drug development programs, medical device designing and research as well as management of regulatory affairs for pharmaceutical and biopharmaceutical companies.

Countries in APAC are facing an increasing incidence of COVID-19. Currently, India is the second worst-hit country worldwide. The COVID-19 pandemic has severely impacted the region; however, it has also allowed stakeholders to realign their future path based on strategic intent and focus. India and China are the most preferred destinations for outsourcing, where a large pool of skilled labor is available at a lower cost. With the increasing pressure to reduce manufacturing costs and accelerate time-to-market, many devices and diagnostics companies are looking to conduct clinical trial operations in APAC. Countries such as China, Japan, Singapore, and South Korea are seeing an increased interest in clinical trials. High costs in western countries are also contributing to the flow of medical affairs outsourcing to APAC. To expand sales to the Asian market, pharmaceutical companies are becoming aware of new and changing regulatory environments for drugs, devices, and in-vitro diagnostics. New or improved regulations are implemented frequently in Asia, including changes in GMP standards, drug price controls, and medical device regulatory systems. Third-party guidance and advice are required as part of any acquisition or any improvement of current standards. Increasingly, third-party outsourcing service providers are playing a greater role in supporting and managing the delivery of the key business functions like drug development, sales and marketing, and regulatory compliance services in APAC.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC medical affairs outsourcing market. The APAC medical affairs outsourcing market is expected to grow at a good CAGR during the forecast period.

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

APAC Medical Affairs Outsourcing Market Segmentation

APAC Medical Affairs Outsourcing Market – By Services

Medical Writing and Publishing
Medical Science Liaisons (MSLs)
Medical Information
Medical Monitoring
Others

APAC Medical Affairs Outsourcing Market – By Application

Pharmaceuticals
Medical Devices
Biopharmaceutical

APAC Medical Affairs Outsourcing Market, by Country

Australia
China
India
Japan
South Korea
Rest of APAC

APAC Medical Affairs Outsourcing Market - Companies Mentioned

ICON PLC
Indegene
IQVIA Inc
PAREXEL INTERNATIONAL CORPORATION
PPD Inc
Syneos Health
UDG Healthcare plc.
WuXi AppTec

Asia-Pacific Medical Affairs Outsourcing Report Scope

Report Attribute	Details
Market size in 2020	US$ 356.69 Million
Market Size by 2027	US$ 776.42 Million
Global CAGR (2020 - 2027)	11.8%
Historical Data	2018-2019
Forecast period	2021-2027
Segments Covered	By Services Medical Writing and Publishing Medical Monitoring Medical Science Liaisons Medical Information By and Application Pharmaceutical Biopharmaceutical Medical Devices
Regions and Countries Covered	Asia-Pacific China India Japan Australia Rest of Asia-Pacific
Market leaders and key company profiles	ICON PLC Indegene IQVIA Inc PAREXEL INTERNATIONAL CORPORATION PPD Inc Syneos Health UDG Healthcare plc. WuXi AppTec

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Asia-Pacific Medical Affairs Outsourcing Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Asia-Pacific Medical Affairs Outsourcing Market Report Snapshots

Our Top Trending Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

Yukihiko Adachi CEO, Deep Blue, LLC.

Reason to Buy

Informed Decision-Making
Understanding Market Dynamics
Competitive Analysis
Customer Insights
Market Forecasts
Risk Mitigation
Strategic Planning
Investment Justification
Identifying Emerging Markets
Enhancing Marketing Strategies
Boosting Operational Efficiency
Tracking Industry Innovations
Aligning with Regulatory Trends

Your Key Concerns Addressed - Question & Answer

Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

Is there support available if I can’t access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

Buy Now

87-673-9708

ISO 9001:2015